We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Net Medical Xpress Solutions Inc (PK) | USOTC:NMXS | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0119 | 0.0053 | 0.0123 | 0.00 | 21:05:09 |
ALBUQUERQUE, NM--(Marketwired - Mar 26, 2014) - Net Medical Xpress Solutions, Inc. (OTCQB: NMXS) announced today its upcoming sponsorship of a new radio show, "The Docs and the CEO."
The show, which will air on Saturday mornings at 10:00 am mountain time, will feature questions and answers from physicians on medical topics and CEOs on the business side of medicine.
The weekly show will air initially on KIVA AM&FM (1600AM and 95.9FM) in Albuquerque as the anchor station. Plans call for a national rollout on stations throughout the U.S. KIVA is known as "Rock of Talk" and airs talk show hosts such as Sean Hannity, Dan Patrick and Andy Dean.
Dr. Tom Pascuzzi, Dr. Dale Averson, and Dr. Jon Marinaro will be the anchor hosts on the medical side. CEO Dick Govatski of Net Medical in Albuquerque will be on the business side.
Special guests, specialists and primary care physicians from Net Medical's staff and experts from around the country will participate on a variety of topics.
The toll free number to reach the program is 855-778-9100. The program will be available nationally on the Internet starting April 5th, 2014 at http://www.rockoftalk.com.
About Net Medical Xpress Solutions, Inc: Net Medical Xpress is a multi-faceted, FDA-regulated company with six operating segments, over 400 physicians under contract, 400,000 cases completed in 2013 and offices in three cities in the U.S. The company provides telemedicine programs for diagnostic and clinical medical services to mobile companies, urgent cares, hospitals, trauma centers, imaging centers, jails, nursing homes, corporate health departments and out patient medical facilities. The company's proprietary, web-based XR-Express 510K FDA-cleared PACS is Net Medical Xpress foundation software, which enables medical providers to make real-time assessments of patients' conditions and treatment needs.
An investment profile for Net Medical Xpress is at http://www.hawkassociates.com/profile/nmxs.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert.
For investor-related questions contact Frank Hawkins, Hawk Associates, at 305-451-1888 or Dick Govatski at 505-255-1999 (ceo@nmxs.com).
This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company's financing plans; (ii) trends affecting the company's financial condition or results of operations; (iii) the company's growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company's ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the company's Forms 10-K and 10-Q filed with the SEC.
For more information: www.netmedical.com www.nmxs.com Dick Govatski President and CEO 505-255-1999 ceo@nmxs.com
1 Year Net Medical Xpress Solut... (PK) Chart |
1 Month Net Medical Xpress Solut... (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions